(Q33945555)

30 July 2017

1 reference

title

Bridging the treatment gap. (English)

1 reference

30 July 2017

Smith SC Jr

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

American Journal of Cardiology

30 July 2017

published in

1 reference

30 July 2017

volume

85

1 reference

30 July 2017

issue

12A

1 reference

30 July 2017

page(s)

3E-7E

1 reference

Contributions of the Framingham Study to the conquest of coronary artery disease

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900944-9

Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900944-9

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900944-9

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900944-9

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900944-9

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900944-9

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900944-9

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900944-9

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900944-9

10.1016/S0002-9149(00)00944-9

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference